T. Rowe Price Associates »

Aeglea Biotherapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $12M 507k 23.28
2024-09-30 $13M 429k 29.41
2024-06-30 $7.3M 308k 23.55
2024-03-31 $3.0M 79k 37.94